be 2254 has been researched along with urapidil in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, G; Hanft, G | 1 |
1 other study(ies) available for be 2254 and urapidil
| Article | Year |
|---|---|
Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Dioxanes; Heart; In Vitro Techniques; Male; Myocardium; Phenethylamines; Phentolamine; Piperazines; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Tetralones; Yohimbine | 1989 |